These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32417461)

  • 1. Prognostic role of pretreatment lactate dehydrogenase in patients with metastatic renal cell carcinoma: A systematic review and meta-analysis.
    Zhang N; Zhang H; Zhu D; JiRiGaLa ; Yu D; Wang C; WuYunBiLiGe ; Amin ; ZhiHong ; Yu H; Chen X; Wang M
    Int J Surg; 2020 Jul; 79():66-73. PubMed ID: 32417461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Serum Lactate Dehydrogenase in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Shen J; Chen Z; Zhuang Q; Fan M; Ding T; Lu H; He X
    PLoS One; 2016; 11(11):e0166482. PubMed ID: 27861542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of performance status in metastatic renal cell carcinoma patients receiving tyrosine kinase inhibitors: a systematic review and meta-analysis.
    Xu Y; Zhang Y; Wang X; Kang J; Liu X
    BMC Cancer; 2019 Feb; 19(1):168. PubMed ID: 30795756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of pretreated serum lactate dehydrogenase level in nasopharyngeal carcinoma among Chinese population: A meta-analysis.
    Zhang M; Wei S; Su L; Lv W; Hong J
    Medicine (Baltimore); 2016 Aug; 95(35):e4494. PubMed ID: 27583859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Role of Serum Lactate Dehydrogenase in Patients With Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
    Wu M; Lin P; Xu L; Yu Z; Chen Q; Gu H; Liu C
    Front Oncol; 2020; 10():677. PubMed ID: 32509573
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertension as a prognostic factor in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: a systematic review and meta-analysis.
    Liu Y; Zhou L; Chen Y; Liao B; Ye D; Wang K; Li H
    BMC Urol; 2019 Jun; 19(1):49. PubMed ID: 31174518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic nutritional index and prognosis in renal cell carcinoma: A systematic review and meta-analysis.
    Kim SI; Kim SJ; Kim SJ; Cho DS
    Urol Oncol; 2021 Oct; 39(10):623-630. PubMed ID: 34253447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of oncologic outcomes between partial and radical nephrectomy for localized renal cell carcinoma: A systematic review and meta-analysis.
    Gu L; Ma X; Li H; Chen L; Xie Y; Li X; Gao Y; Zhang Y; Zhang X
    Surg Oncol; 2016 Dec; 25(4):385-393. PubMed ID: 27916170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
    Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
    Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of Sarcomatoid Differentiation in Patients With Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Zhi H; Feng M; Liu S; Na T; Zhang N; BiLiGe W
    Front Oncol; 2020; 10():591001. PubMed ID: 33134181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Lactate Dehydrogenase in Patients with Hepatocellular Carcinoma: A Meta-Analysis.
    Kong W; Zuo X; Liang H; Hu J; Zhang H; Wang X; Chen W
    Biomed Res Int; 2018; 2018():1723184. PubMed ID: 30687735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Lactate Dehydrogenase in Metastatic Prostate Cancer: A Systematic Review and Meta-analysis.
    Mori K; Kimura S; Parizi MK; Enikeev DV; Glybochko PV; Seebacher V; Fajkovic H; Mostafaei H; Lysenko I; Janisch F; Egawa S; Shariat SF
    Clin Genitourin Cancer; 2019 Dec; 17(6):409-418. PubMed ID: 31558410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment elevated serum lactate dehydrogenase as a significant prognostic factor in malignant mesothelioma: A meta-analysis.
    Zhuo Y; Lin L; Wei S; Zhang M
    Medicine (Baltimore); 2016 Dec; 95(52):e5706. PubMed ID: 28033270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of lactate deshydrogenase levels on non-small cell lung cancer prognosis: a meta-analysis.
    Gong T; Liu J; Jiang J; Zhai YF; Wu CM; Ma C; Wen BL; Yan XY; Zhang X; Wang DM; Lu Q; Qu YL
    Cell Mol Biol (Noisy-le-grand); 2019 Jan; 65(1):89-93. PubMed ID: 30782303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of metastasectomy on overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysis.
    Hsieh PY; Hung SC; Li JR; Wang SS; Yang CK; Chen CS; Lu K; Cheng CL; Chiu KY
    Urol Oncol; 2021 Jul; 39(7):422-430. PubMed ID: 33934963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of pretreatment serum lactate dehydrogenase level in patients with solid tumors: a systematic review and meta-analysis.
    Zhang J; Yao YH; Li BG; Yang Q; Zhang PY; Wang HT
    Sci Rep; 2015 Apr; 5():9800. PubMed ID: 25902419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative apolipoprotein B/A1 ratio is an independent prognostic factor in metastatic renal cell carcinoma.
    Zhang F; Xie Y; Ma X; Gu L; Li H; Li X; Guo G; Zhang X
    Urol Oncol; 2019 Mar; 37(3):184.e9-184.e17. PubMed ID: 30509867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour burden is an independent prognostic factor in metastatic renal cell carcinoma.
    Iacovelli R; Lanoy E; Albiges L; Escudier B
    BJU Int; 2012 Dec; 110(11):1747-53. PubMed ID: 23106948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma.
    Fu Y; Lan T; Cai H; Lu A; Yu W
    Medicine (Baltimore); 2018 May; 97(19):e0741. PubMed ID: 29742740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and meta-analysis of clinicopathologic factors linked to oncologic outcomes for renal cell carcinoma with tumor thrombus treated by radical nephrectomy with thrombectomy.
    Gu L; Li H; Wang Z; Wang B; Huang Q; Lyu X; Shen D; Gao Y; Fan Y; Li X; Xie Y; Du S; Liu K; Tang L; Peng C; Ma X; Zhang X
    Cancer Treat Rev; 2018 Sep; 69():112-120. PubMed ID: 29960124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.